IMXI
International Money Express, Inc.
IMXI trails on the overall score without a compensating advantage in the available component scores.
MU
Micron Technology, Inc.
MU has the edge over IMXI overall, supported by stronger modeled upside and stronger fundamentals.
IMXI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Healthy | |
| Strong |
IMXI's cash flow and balance sheet are currently healthy, and its profitability is stable, but its revenue is under pressure.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
IMXI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.4x | $6.39 | — |
| Cheap | 11x | $6.63 | +3.8% |
| Current | 11x | $6.39 | — |
| Fair | 15x | $8.92 | +40% |
| Expensive | 19x | $11.18 | +75% |
Historical ranges are pointers, not guarantees.
IMXI's PE is in its cheap range at 11x. On analysts' estimates for next year's earnings, today's price would be 7.4x.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over IMXI in the historical PE scenario, which offers more potential upside but is not a forecast.
IMXI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect IMXI's earnings and revenue to decline, with profitability weakening.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over IMXI on the outlook, with more favorable earnings and revenue expectations.
IMXI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.86 | +46% |
| Q3 2026 | $0.59 | -54% |
| Q2 2026 | $0.62 | -62% |
| Q1 2026 | $0.85 | -50% |
| Q4 2025 | $1.08 | -40% |
| Q3 2025 | $1.28 | -28% |
| Q2 2025 | $1.64 | -1.8% |
| Q1 2025 | $1.69 | +1.2% |
| Q4 2024 | $1.79 | +9.8% |
IMXI's earnings per share have fallen from their peak: $0.59 over the past year, against $1.79 in late 2024.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over IMXI on earnings, with more consistent year-over-year improvement.
IMXI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $126.4M | -18% |
| Q2 2026 | $131.2M | -19% |
| Q1 2026 | $122M | -15% |
| Q4 2025 | $147.4M | -11% |
| Q3 2025 | $154.9M | -9.9% |
| Q2 2025 | $161.1M | -6.1% |
| Q1 2025 | $144.3M | -4.1% |
| Q4 2024 | $164.8M | -4.1% |
IMXI's revenue has slid since its 2023 peak: $126M last quarter, down 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.2% | +0.4 points |
| Q2 2026 | 6.7% | -5.4 points |
| Q1 2026 | 3% | -6.7 points |
| Q4 2025 | 7.8% | -7.1 points |
| Q3 2025 | 6.8% | -9.4 points |
| Q2 2025 | 12% | -1.3 points |
| Q1 2025 | 9.8% | -3.3 points |
| Q4 2024 | 15% | -1.1 points |
IMXI's operating margin was 7.2% last quarter, about level with the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over IMXI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over IMXI on profitability, with a higher operating margin.
IMXI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.3M | +$38.8M |
| Q2 2026 | $107.2M | +203% |
| Q1 2026 | -$42.9M | -219% |
| Q4 2025 | -$20M | -$11.2M |
| Q3 2025 | -$35.5M | -252% |
| Q2 2025 | $35.3M | +$61.6M |
| Q1 2025 | $36M | +3.6% |
| Q4 2024 | -$8.8M | -116% |
IMXI still generates free cash flow, though less than at its 2026 peak: $48M over the past year.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over IMXI on cash flow, with more consistent year-over-year improvement.
IMXI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | 1.1x | Healthy |
| Q4 2025 | 0.4x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | 0.2x | Very low |
IMXI has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
IMXI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 21.9 | Oversold |
| Stochastic | 7.3 | Oversold |
IMXI's weekly RSI is 22 (oversold) and its Stochastic is 7 (oversold).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
IMXI PE vs Technology Sector
| Metric | IMXI | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 14 | 35 | 21 pts below |
IMXI is trading at 11x earnings, a 61% discount to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over IMXI on valuation relative to its sector.
IMXI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.74 | 34% below |
| 20 week MA | $12.1 | 47% below |
| 50 week MA | $14.1 | 55% below |
| 100 week MA | $14.1 | 55% below |
| 200 week MA | $17.6 | 64% below |
IMXI is in a downtrend: it's below all five of its weekly moving averages, and 64% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over IMXI on trend strength, trading above more of its moving averages.
IMXI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.0 | $15.9 | +32% |
| 2021 | $15.9 | $15.8 | -0.6% |
| 2022 | $15.8 | $22.5 | +43% |
| 2023 | $22.5 | $22.1 | -1.6% |
| 2024 | $22.1 | $20.6 | -6.6% |
| 2025 | $20.6 | $15.4 | -25% |
| 2026 YTD | $15.4 | $6.39 | -59% |
IMXI has finished three years in a row lower, and it's down 59% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over IMXI on returns for 2026, with the stronger performance.